Acutaas Chemicals Ltd.

₹4,039.1

43 (1.1%)

ACUTAAS Share Price

Pharmaceuticals & Biotechnology

As on November 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 33,100.1 Cr

P/E Ratio92.82

Dividend Yield0.01 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	3,952.32	Bullish
10-DMA	3,889.29	Bullish
20-DMA	3,684.5	Bullish
50-DMA	3,414.82	Bullish
100-DMA	3,386.79	Bullish
200-DMA	2,929.59	Bullish

Historical Performance

1 Year

140.1%

3 Years

647.4%

5 Years

693.5%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	13,394	10,069	7,175	6,167	5,201
Total Expenditure	8,590	7,748	5,890	4,941	4,150
Other Income	416	169	75	43	28
Operating Profit	5,220	2,490	1,360	1,269	1,079
Interest	33	62	59	24	64
Depreciation	360	266	161	123	101
Profit Before Tax	4,827	2,162	819	1,122	915
Consolidated Net Profit	3,563	1,587	428	833	719
Adjusted EPS	44	10	6	11	10

Compounded Sales Growth

10 Years:54.2

5 Years:31.5

3 Years:16.8

TTM:5.9

Compounded Profit Growth

10 Years:94.9

5 Years:45.8

3 Years:33.7

TTM:17.6

Stock Price CAGR

10 Years:N/A

5 Years:51.3

3 Years:95.5

TTM:136.2

Return on Equity

10 Years:1.9

5 Years:9.9

3 Years:5.8

last year:43.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	409	409	369	364	364
Total Reserves	16,095	12,686	6,348	5,575	4,858
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	424	269	1,280	101	73
Other Current Liabilities	124	135	648	66	49
Short Term Borrowings	265	82	726	28	---
Total Liabilities	19,840	15,493	10,959	7,669	6,589
Capital Work in Progress	3,323	1,303	1,254	255	19
Long Term Loans & Advances	244	559	486	172	142
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	572	692	725	411	431
Total Current Assets	8,813	7,916	4,933	4,571	4,296
Total Assets	19,840	15,493	10,959	7,669	6,589
Adjusted Book Value	202	80	91	82	143

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 92.82, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 95.9%, indicating sustained price appreciation.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹5220 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹13394 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 2360528.3

No. of Shares: 584 (Approx)

Performance:136.1%

1360528.3

NIFTY Performance: -3%

1 day Top Gainers